| 2025 | 2024 | 2023 | 2022 | 2021 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 58,2 M € | +1.8% | 57,1 M € | -0.8% | 57,6 M € | +18.2% | 48,7 M € | +35.4% | 36,0 M € | +138.9% | 15,1 M € | +17.2% | 12,8 M € | +24.4% | 10,3 M € | +26.6% | 8,2 M € | +38.3% | 5,9 M € | +11.1% | 5,3 M € | -35.2% | 8,2 M € | -37.3% | 13,1 M € | -6.9% | 14,0 M € | — | — | — | ||||
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1,3 M € | +351.0% | -505,1 k € | -519.9% | 120,3 k € | |||||||||||||||
| EBITDA | 3,1 M € | -8.4% | 3,4 M € | +4.9% | 3,2 M € | +30.5% | 2,5 M € | +35.9% | 1,8 M € | +173.2% | 667,6 k € | +6.5% | 627,0 k € | +23.9% | 506,1 k € | +5.8% | 478,1 k € | +27.9% | 373,9 k € | -12.5% | 427,5 k € | -80.3% | 2,2 M € | -39.7% | 3,6 M € | +121.7% | 1,6 M € | +931.5% | 157,6 k € | +110.3% | -1,5 M € | -910.9% | -152,1 k € | |
| Operating profit | 2,0 M € | +3.6% | 1,9 M € | -1.1% | 2,0 M € | +53.5% | 1,3 M € | +51.5% | 846,4 k € | +92.9% | 438,8 k € | +8.6% | 404,0 k € | +12.4% | 359,3 k € | +11.4% | 322,6 k € | +50.7% | 214,1 k € | -23.5% | 279,8 k € | -85.9% | 2,0 M € | -39.4% | 3,3 M € | +150.2% | 1,3 M € | +930.3% | -157,5 k € | +91.2% | -1,8 M € | -394.3% | -360,2 k € | |
| Profit/loss | 1,4 M € | -2.0% | 1,5 M € | -9.9% | 1,6 M € | +66.8% | 975,0 k € | +50.1% | 649,7 k € | +162.4% | 247,6 k € | +9.0% | 227,2 k € | -2.9% | 234,1 k € | -37.2% | 372,6 k € | +17.8% | 316,1 k € | -19.9% | 394,5 k € | -72.1% | 1,4 M € | -47.9% | 2,7 M € | +175.9% | 982,2 k € | +370.3% | -363,4 k € | +80.9% | -1,9 M € | -365.9% | -409,3 k € | |
| Equity | 17,1 M € | +9.2% | 15,7 M € | +10.3% | 14,2 M € | +69.6% | 8,4 M € | +13.2% | 7,4 M € | +44.5% | 5,1 M € | +5.1% | 4,9 M € | +4.9% | 4,6 M € | -38.2% | 7,5 M € | +5.2% | 7,1 M € | +4.6% | 6,8 M € | +6.1% | 6,4 M € | +28.2% | 5,0 M € | +117.7% | 2,3 M € | +74.4% | 1,3 M € | +619.1% | 183,6 k € | -91.2% | 2,1 M € | |
| Total assets | 25,6 M € | -3.9% | 26,6 M € | -8.5% | 29,1 M € | +48.3% | 19,6 M € | +6.2% | 18,5 M € | +120.8% | 8,4 M € | +36.7% | 6,1 M € | +3.5% | 5,9 M € | -35.6% | 9,2 M € | +3.9% | 8,8 M € | +3.6% | 8,5 M € | -3.1% | 8,8 M € | +8.2% | 8,1 M € | +39.2% | 5,8 M € | -1.3% | 5,9 M € | +23.2% | 4,8 M € | +8.1% | 4,4 M € | |
| Cash | 218,1 k € | -85.2% | 1,5 M € | -70.7% | 5,0 M € | +4552.6% | 108,5 k € | -93.5% | 1,7 M € | +1666.8% | 94,0 k € | -93.1% | 1,4 M € | +400.4% | 273,8 k € | +78.0% | 153,8 k € | +139.9% | 64,1 k € | +7.9% | 59,4 k € | -54.9% | 131,8 k € | -86.0% | 941,1 k € | +83.0% | 514,2 k € | +720.6% | 62,7 k € | -89.5% | 598,9 k € | +57.8% | 379,5 k € | |
| Debts | 8,5 M € | -22.0% | 10,8 M € | -27.1% | 14,9 M € | +32.4% | 11,2 M € | +1.5% | 11,1 M € | +241.2% | 3,2 M € | +160.1% | 1,2 M € | -0.3% | 1,3 M € | -24.7% | 1,7 M € | -1.2% | 1,7 M € | -0.9% | 1,7 M € | -28.6% | 2,4 M € | -23.9% | 3,1 M € | -11.8% | 3,5 M € | -23.0% | 4,6 M € | -0.5% | 4,6 M € | +96.1% | 2,4 M € | |
| Staff | 156,5 | 160,4 | 160,9 | 136,9 | 111,3 | 59 | 54,2 | 42,4 | 37,4 | 29,2 | 27,8 | 30,6 | 40,7 | 35,2 | 21,3 | 14,8 | 9,5 | |||||||||||||||||
Private limited company · Leuven · incorporated on 20/02/2006 · 156,5 ETP
Private limited company profitable and well capitalised. Cash position declining (-85.2%).
Solid counterparty for a standard engagement.
MEDPACE LABORATORIES is a Private limited company incorporated in 2006. Its main activity is: Pre-primary education. Its registered office is in Leuven. It employs on average 156,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette